110 related articles for article (PubMed ID: 31021836)
1. FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Chen ZH; Wang LH
Am J Dermatopathol; 2019 Dec; 41(12):908-913. PubMed ID: 31021836
[TBL] [Abstract][Full Text] [Related]
2. Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
Yan H; Zhu C; Zhang L
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22409. PubMed ID: 31617652
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
4. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract][Full Text] [Related]
5. NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3β/β-catenin pathway.
Hu W; Li X; Cheng R; Ke J; Liu Y; Ma M; Cao Y; Liu D
Arch Dermatol Res; 2019 Jul; 311(5):399-410. PubMed ID: 30997569
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
7. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
[TBL] [Abstract][Full Text] [Related]
8. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the expression of the lncRNA MIAT inhibits melanoma migration and invasion through the PI3K/AKT signaling pathway.
Yang Y; Zhang Z; Wu Z; Lin W; Yu M
Cancer Biomark; 2019; 24(2):203-211. PubMed ID: 30614798
[TBL] [Abstract][Full Text] [Related]
11. [Butein promotes the role of mH2A in MAPK signaling pathway through targeting GRP78 in regulating biological behaviors of melanoma].
Yang J; Deng F; Pan N
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1129-1135. PubMed ID: 29093242
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
He D; Wu Z; He J; Wang Y; Li Z; Gao S
Gene; 2019 May; 696():47-53. PubMed ID: 30771479
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of son of sevenless homolog 1 is predictive of poor prognosis in uveal malignant melanoma patients.
Wang YS; Wu L
Ophthalmic Genet; 2019 Feb; 40(1):22-28. PubMed ID: 30714452
[TBL] [Abstract][Full Text] [Related]
14. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway.
Lu S; Xu Q
IUBMB Life; 2019 May; 71(5):587-600. PubMed ID: 30589231
[TBL] [Abstract][Full Text] [Related]
16. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
[TBL] [Abstract][Full Text] [Related]
17. Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells.
Huang YX; Song H; Tao Y; Shao XB; Zeng XS; Xu XL; Qi JL; Sun JF
PLoS One; 2018; 13(4):e0195610. PubMed ID: 29684087
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor-like-1: a new therapeutic target and unfavorable prognostic indicator for rectal adenocarcinoma.
Jia RZ; Zhang JZ; Jing CQ; Li CS; Zhuo HQ
J Recept Signal Transduct Res; 2020 Jun; 40(3):257-263. PubMed ID: 32098557
[TBL] [Abstract][Full Text] [Related]
19. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
20. MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1.
Schwaid AG; Su C; Loos P; Wu J; Nguyen C; Stone KL; Kanyo J; Geoghegan KF; Bhattacharya SK; Dow RL; Buckbinder L; Carpino PA
ACS Chem Biol; 2015 Dec; 10(12):2667-71. PubMed ID: 26422651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
